IbisVision (Health Care, Life Sciences) — Funding, Investors & Signals 2026

IbisVision

Early Detection of Glaucoma with Innovative Eye Test

Founded 2013 2-10 employees Series Unknown Total: $4.56M Health Care, Life Sciences +1

IbisVision is a Health Care startup founded in 2013, with the slogan "Early Detection of Glaucoma with Innovative Eye Test". The company has developed 'Ring of Sight' (ROS), an eye test geared towards the early detection of glaucoma. The condition is the second most common cause of blindness globally and poses a significant public health challenge. IbisVision's innovative solution aims to address this by facilitating early diagnosis, which is crucial given the irreversibility of detected damage. ROS leverages patented technology for visual field testing, employing a cursor and LED screen. The application, currently optimized for the Windows environment, features two main tests: the Full Threshold Test and the Suprathreshold Test. Notably, ROS is hosted remotely and utilizes advanced Cloud technology, allowing users to access it from any location. The company prioritizes data security and privacy, with all information stored on secure, encrypted servers. The company recently secured a significant £4.50M Venture Round investment on 11th May 2023, with participation from distinguished investors including Scottish Enterprise, Deepbridge Capital, and Compiler Venture Capital. This infusion of capital bodes well for IbisVision's growth and underscores investor confidence in the company's potential to make a meaningful impact in the field of eye health.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	••••••	3	•••• ••••	11 May 2023
Grant	••••••	1		01 Jun 2021
Seed Round	••••••	1		01 Jan 2014

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

••••••

•••• ••••

11 May 2023

Grant

••••••

01 Jun 2021

Seed Round

••••••

01 Jan 2014

FAQ About IbisVision

Early Detection of Glaucoma with Innovative Eye Test

IbisVision was founded in 2013.

IbisVision operates in the following industries: Health Care, Life Sciences, Medical Devices.

IbisVision has approximately 2-10 employees.

IbisVision has completed 3 funding rounds, raising a total of $4.56M. The latest funding stage is Series Unknown.

Top alternatives and competitors to IbisVision include Nova Eye Medical, JL Eye Specialists, New Path Vision, Spect, Mittleman Eye. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

IbisVision and Nova Eye Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

IbisVision

General Information

Track IbisVision

Discover More

About IbisVision

Funding Rounds & Investors (3)

IbisVision Alternatives & Competitors

FAQ About IbisVision

Don't just browse. Track.